The Pennant Group (NASDAQ:PNTG) Releases FY 2024 Earnings Guidance

The Pennant Group (NASDAQ:PNTG) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.900-0.960 for the period, compared to the consensus earnings per share estimate of 0.910. The company issued revenue guidance of $665.3 million-$706.5 million, compared to the consensus revenue estimate of $679.3 million.

The Pennant Group Stock Performance

PNTG traded up $1.42 on Friday, hitting $33.42. 262,213 shares of the company’s stock were exchanged, compared to its average volume of 198,817. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.48. The stock has a fifty day moving average of $33.80 and a two-hundred day moving average of $28.37. The Pennant Group has a twelve month low of $11.95 and a twelve month high of $37.13. The firm has a market cap of $1.01 billion, a PE ratio of 49.15, a P/E/G ratio of 3.41 and a beta of 2.02.

The Pennant Group (NASDAQ:PNTG) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.02. The business had revenue of $168.75 million for the quarter, compared to the consensus estimate of $156.71 million. The Pennant Group had a return on equity of 14.02% and a net margin of 3.24%. On average, research analysts anticipate that The Pennant Group will post 0.75 earnings per share for the current fiscal year.

Analyst Ratings Changes

PNTG has been the topic of a number of analyst reports. Royal Bank of Canada increased their price objective on shares of The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a report on Wednesday, October 23rd. Truist Financial raised their price target on shares of The Pennant Group from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Oppenheimer boosted their price objective on The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a research report on Friday. Finally, Stephens restated an “overweight” rating and issued a $40.00 target price on shares of The Pennant Group in a research report on Wednesday, October 9th.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.